---
figid: PMC9303316__BCP-88-2875-g004
pmcid: PMC9303316
image_filename: BCP-88-2875-g004.jpg
figure_link: /pmc/articles/PMC9303316/figure/bcp15191-fig-0002/
number: FIGURE 2
figure_title: ''
caption: Effects of the genetic instruments on IL‐6 and IL‐6R levels. Forest plots
  representing the change in IL‐6 and IL‐6R levels for all genetic instruments, scaled
  to a 1 mg/L reduction in CRP levels. The bracket marks an association of the genetic
  instrument with IL‐6 or IL‐6R that meets the multiple testing threshold (8.92 × 10−4).
  CRP, C‐reactive protein; IL‐6, Interleukin‐6
article_title: 'Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian
  randomization study on both IL6 and IL6R .'
citation: Arjen J. Cupido, et al. Br J Clin Pharmacol. 2022 Jun;88(6):2875-2884.
year: '2022'

doi: 10.1111/bcp.15191
journal_title: British Journal of Clinical Pharmacology
journal_nlm_ta: Br J Clin Pharmacol
publisher_name: John Wiley and Sons Inc.

keywords:
- cardiovascular disease
- classical signalling
- IL‐6
- trans‐signalling

---
